# Comparison of Exparel to Bupivacaine With Dexamethasone in TAP Block

> **NCT02179892** · PHASE4 · TERMINATED · sponsor: **Colette Curtis MD** · enrollment: 9 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Bupivacaine Extended-Release Liposome Injection (Exparel)
- **DRUG:** Bupivacaine and Dexamethasone Injection
- **DRUG:** IV Acetaminophen
- **DRUG:** Oral Acetaminophen

## Key facts

- **NCT ID:** NCT02179892
- **Lead sponsor:** Colette Curtis MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-07
- **Primary completion:** 2015-06-06
- **Final completion:** 2015-06-06
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Inadequate patient population to complete enrollment
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02179892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02179892, "Comparison of Exparel to Bupivacaine With Dexamethasone in TAP Block". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02179892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*